04 Sep 2017

FDA Clearance for the OCULUS Pentacam® AXL with Optical Biometry

FDA Clearance for the OCULUS Pentacam® AXL with Optical Biometry

The new OCULUS Pentacam® AXL has received the 510(k) clearance of the US Food and Drug Administration (FDA). The Pentacam® AXL represents the systematic further development of the successful and time-proven Pentacam® HR. Anterior segment tomography and optical biometry – all in one device and with a single measuring operation.

The intuitive and network-compatible IOL calculation software offers solutions to nearly every challenge. Standard formulas, such as formulas for treated corneas, for toric IOLs, and ray-tracing formulas, are already integrated. The calculation of toric IOLs is based on the total corneal refractive power (TCRP), thus taking the influence of the posterior corneal surface into account. A comprehensive IOL database with IOL constants for the Pentacam® AXL is also integrated.

The Pentacam® AXL offers a well-targeted screening process, Fast Screening Report, Belin/Ambrósio Enhanced Ectasia Display (early detection of corneal ectasia) and densitometric evaluation (Corneal Optical Densitometry & PNS) for every cataract patient. Whether aspherical, toric or multifocal: with the Cataract Pre-OP Display, the premium IOL can be selected in 4 steps.

The IOL constants optimization from Prof. Wolfgang Haigis permits a continuous enhancement of the results. Surgical data and post-refractive examination findings are secured with just a few clicks.

For further information on the new Pentacam® AXL please contact your local OCULUS distributor or visit the website at www.pentacam.com.